Gastrointestinal Endoscopic Devices Market Sales, Revenue and Growth Rate 2030

Health

Global Gastrointestinal MedTech Devices Market Overview
The Global Gastrointestinal (GI) MedTech Devices Market, valued at $13.7 billion in 2021, is projected to grow at a CAGR of 5% over the next five years. Growth is driven by the increasing number of GI procedures, rising adoption of minimally invasive surgeries, and the growing use of single-use devices to minimize cross-contamination and enhance patient safety. The rising prevalence of colorectal cancer, screening mandates across healthcare systems, growing hospital investments in endoscopy facilities, and the clinical advantages of endoscopic procedures are also fueling market expansion.

Download Sample Copy: https://meditechinsights.com/gastrointestinal-endoscopic-devices-market/request-sample/

Understanding Gastrointestinal Diseases and Device Demand
Gastrointestinal diseases affect the digestive tract, including the mouth, esophagus, stomach, intestines, rectum, anus, and associated organs such as the liver, gallbladder, and pancreas. The global burden of conditions like colorectal cancer, gastroesophageal reflux disease, ulcerative colitis, inflammatory bowel disease, and Crohn’s disease continues to rise, influenced by lifestyle and environmental changes such as diet shifts, industrialization, sanitation improvements, and antibiotic usage. Medical devices such as endoscopes, laparoscopes, surgical endoscopes, and endotherapy systems play a crucial role in early and accurate diagnosis and treatment, creating significant growth opportunities for GI device manufacturers.

Resurgence of Gastrointestinal Endoscopic Devices Market Post COVID-19
The COVID-19 pandemic significantly disrupted the GI MedTech industry due to lockdowns, staffing shortages, and reduced elective procedures. Gastroenterology departments worldwide saw reduced procedure volumes, postponed non-urgent cases, and revenue declines in endoscopic device sales. However, since 2021, the market has been on a recovery path. The rebound has been driven by increased procedure volumes, new product launches, and robust sales across Japan, Europe, and North America. As global healthcare systems stabilize and procedure backlogs clear, demand for GI endoscopy devices is strengthening.

See also  Medical Aesthetics Market: Future Growth, Emerging Trends, and 12% CAGR Expansion Through 2030

Expert Insight
“A price erosion in Gastrointestinal Endoscopic Devices is expected due to consolidation of group purchasing organizations (GPOs) in different markets and the demand for discounts by cash-strapped hospitals making high-volume purchases, especially post-pandemic.” — Senior Director, Leading Endoscope Manufacturer, United States.

Technological Advancements Fueling Market Growth
The GI Endoscopic Devices market is characterized by rapid innovation and continuous technological improvements.

  • In May 2022, Fujifilm showcased its cutting-edge endoscopy portfolio at Digestive Disease Week, featuring innovations such as the ELUXEO® VISION platform, G-EYE® 700 Series Colonoscopes, EL-740D/S Dual-Channel Endoscope, and TRACMOTION for endoscopic submucosal dissection.
  • In February 2022, Ambu received FDA 510(k) clearance for its Ambu® aScope™ Gastro and Ambu® aBox™ 2 systems. The aScope Gastro is the first sterile single-use gastroscope featuring advanced imaging and ergonomic design, while the aBox 2 delivers HD-quality imaging and forms the core of Ambu’s next-generation endoscopy ecosystem.

Expert Perspective
“Single-use gastroscopes address challenges such as long waiting lists and staff shortages. Their easy setup and elimination of reprocessing are key advantages driving adoption.” — Professor, Leading Hospital, United States.

See also  Global Urology Devices Market Overview The global urology devices market is poised for steady expansion and is projected to grow at a CAGR of approximately 6–7% during the forecast period from 2024 to 2029. This growth trajectory is primarily driven by the rising prevalence of urological disorders and urological cancers across both developed and developing regions. Key Request a free sample copy or view report summary: https://meditechinsights.com/urology-devices-market/request-sample/ An increasing global geriatric population is significantly contributing to market growth, as aging individuals are more prone to conditions such as benign prostatic hyperplasia, urinary incontinence, kidney stones, and bladder dysfunction. Advancements in urology treatment modalities and medical technologies are enabling more accurate diagnosis and effective treatment of complex urological conditions. Despite positive growth prospects, the high initial cost associated with advanced urology equipment and the shortage of skilled urologists in certain regions may restrain market expansion to some extent. Definition and Scope of Urology Devices Urology devices comprise a broad range of medical instruments and equipment used for the diagnosis, monitoring, and treatment of disorders affecting the urinary tract and male reproductive system. These devices are widely utilized in hospitals, specialty clinics, ambulatory surgical centers, and urology practices. Common urology devices include endoscopes, catheters, laser systems, lithotripters, robotic surgical systems, and various surgical instruments. Urology devices play a critical role in managing conditions such as kidney stones, prostate cancer, urinary incontinence, erectile dysfunction, and bladder disorders. Continuous innovation in this field is improving procedural efficiency, patient comfort, and clinical outcomes. Shift Toward Minimally Invasive Urological Procedures The urology devices market is witnessing a strong shift toward minimally invasive surgical procedures. Minimally invasive techniques offer significant advantages, including reduced hospital stays, shorter recovery times, and lower risk of post-operative complications. Procedures such as laparoscopic and robotic-assisted surgeries are becoming increasingly common in urology practices. Endoscopic devices and laser-based technologies are widely used for stone removal, prostate treatments, and tumor ablation. The growing preference for minimally invasive approaches is driving demand for advanced urology devices with enhanced precision and control. Integration of Digital Technologies in Urology Digital transformation is playing an increasingly important role in the evolution of the urology devices market. The integration of artificial intelligence is enhancing diagnostic accuracy and supporting clinical decision-making in urology procedures. Advanced imaging systems provide real-time visualization, enabling urologists to perform complex procedures with greater confidence. Telemedicine solutions are improving patient access to urology consultations, particularly in remote and underserved regions. Digital platforms are also enabling better treatment planning, patient monitoring, and post-procedure follow-up. Technological Advancements Driving Market Growth Rapid technological advancements are a key factor fueling growth in the urology devices market. Innovations in robotics have significantly improved the precision of procedures such as prostatectomy and nephrectomy. Robotic-assisted urological surgeries allow for enhanced dexterity, improved visualization, and greater surgical accuracy. Laser technologies used in lithotripsy and soft tissue ablation are becoming more efficient and safer for patients. Enhanced imaging systems and navigation technologies are reducing procedural risks and improving overall outcomes. Impact of Aging Population on Urology Device Demand The aging global population is a major driver of demand for urology devices. Older adults are more susceptible to urological conditions due to physiological changes and age-related degeneration. Benign prostatic hyperplasia is highly prevalent among elderly men and often requires long-term management or surgical intervention. Urinary incontinence and bladder dysfunction are also common among aging populations, increasing the need for diagnostic and therapeutic devices. As life expectancy continues to rise, the demand for urology devices is expected to grow steadily. Rising Incidence of Urological Disorders The prevalence of urological disorders is increasing globally, contributing significantly to market growth. Lifestyle-related factors such as obesity, diabetes, smoking, and poor dietary habits are increasing the risk of urological diseases. Kidney stones are becoming more common due to changes in diet and fluid intake patterns. Rising incidence of prostate and bladder cancers is driving demand for advanced diagnostic and treatment devices. Early diagnosis and effective management of these conditions rely heavily on modern urology devices. Growth Opportunities in Emerging Markets Emerging markets are expected to offer significant growth opportunities for the urology devices market. Rapid urbanization and improving healthcare infrastructure are enhancing access to specialized urological care. Governments in emerging economies are increasing investments in healthcare modernization and medical equipment procurement. Rising awareness of urological health and availability of trained specialists are further supporting market expansion. The growing middle-class population and increasing healthcare expenditure are driving demand for advanced urology devices in these regions. Challenges Limiting Market Expansion High acquisition and maintenance costs of advanced urology devices pose a challenge for healthcare providers, particularly in resource-limited settings. Limited availability of skilled urologists and trained technicians can restrict the adoption of sophisticated technologies. Regulatory approval processes and compliance requirements may increase time-to-market for new devices. Reimbursement constraints in certain healthcare systems may limit patient access to advanced urology procedures. Impact of Private Equity Investment in Urology Practices Private equity investment is emerging as an important growth catalyst within the urology devices market. Financial backing from private equity firms enables urology practices to improve operational efficiency and expand service offerings. Access to capital allows practices to invest in advanced urology devices and cutting-edge technologies. Private equity involvement supports consolidation and modernization of fragmented urology practices. Between January 2018 and 2022, only 26 urology-related private equity deals were recorded, indicating significant untapped consolidation potential. In comparison, other specialties such as dermatology, orthopedics, gastroenterology, and cardiology have seen substantially higher deal activity. A large proportion of practicing urologists are nearing retirement age, creating opportunities for private equity-led acquisitions. According to the American Urological Association, more than 55% of private practice urologists were aged 65 or older in 2022. Private equity deals offer retiring physicians the option to maintain ownership stakes while transitioning out of clinical practice. Competitive Landscape Analysis The global urology devices market is highly competitive, with the presence of established multinational corporations and specialized medical device companies. Leading players focus on continuous innovation, product differentiation, and portfolio expansion to maintain competitive advantage. Strategic acquisitions and mergers are commonly used to strengthen market presence and expand technological capabilities. Partnerships with healthcare providers and research institutions support product development and clinical validation. New product launches targeting minimally invasive and digitally integrated solutions are shaping competitive dynamics. Future Outlook of the Urology Devices Market The urology devices market is expected to witness sustained growth driven by technological innovation and increasing disease burden. Ongoing advancements in robotics, imaging, and digital health will continue to transform urological care. Replacement demand and technology upgrades will support steady growth in developed markets. Emerging economies will present strong expansion opportunities due to improving healthcare access and rising patient awareness. Overall, the global urology devices market offers attractive long-term growth potential supported by demographic trends, innovation, and expanding clinical applications. Key Players in the Global Urology Devices Market •Boston Scientific Corporation •Medtronic •Coloplast •Baxter International •Becton Dickinson •Stryker Corporation •Olympus Corporation •ConvaTec •B. Braun Melsungen AG •Fresenius Medical Care Get Free Sample Report: https://meditechinsights.com/urology-devices-market/request-sample/ About Medi-Tech Insights Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers

United States to Maintain Market Leadership
The United States currently dominates the Global Gastrointestinal Endoscopic Devices Market and is expected to retain its leading position in the coming years. Contributing factors include the rising number of endoscopic procedures, an aging population, favorable reimbursement policies, the growing preference for minimally invasive therapies, and heightened awareness regarding infection control and device sterilization standards.

Market Strategies and Competitive Developments
The GI Endoscopic Devices market is highly competitive, featuring both established leaders and emerging players. Companies are pursuing organic and inorganic strategies, including new product launches and partnerships, to strengthen their market presence.

  • In February 2022, Motus GI received FDA clearance for the Pure-Vu® EVS System, designed to enhance colonoscopy preparation through improved setup speed, better navigation, and superior cleansing capabilities.
  • In November 2021, Micro-Tech Endoscopy launched the Lesion Hunter Cold Snare, featuring an ultra-thin Nitinol wire for effective tissue trapping and precise lesion resection.
See also  Cell-Based Assays Market Size, Share, Demand, Growth, Demand by Forecast to 2029

Competitive Landscape
Major players in the GI Endoscopic Devices Market include Olympus, Boston Scientific, Pentax (Hoya), Fujifilm, Cook Medical, Karl Storz, Ethicon, Medtronic, Stryker, Medi-Globe, Ambu, Arthrex, Richard Wolf, ERBE, and Micro-Tech, among others.

Future Outlook
The Gastrointestinal Endoscopic Devices Market is expected to maintain steady growth in the years ahead, supported by the increasing prevalence of GI disorders, growing procedural volumes, continued technological innovation, and rising demand for advanced endoscopic and laparoscopic solutions for both diagnostic and therapeutic applications.

Key Request a free sample copy or view report summary:
https://meditechinsights.com/gastrointestinal-endoscopic-devices-market/request-sample/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Leave a Reply